Light therapy is linked to reduced symptoms of depression and improved sleep quality in patients with neuropsychiatric ...
The study comes months after the Advisory Committee on Immunization Practices (ACIP) voted in December 2025 to replace its ...
While negative experiences during early life are known to disrupt gut-brain axis development, the mechanisms linking ...
Patients with surgical complications during cesarean delivery have a higher risk for postpartum readmission within 42 days ...
People with comorbid alcohol use disorder and obesity may represent a distinct clinical subgroup, with glucose dysregulation ...
Global health agencies are accelerating vaccine and therapeutic research because the Bundibugyo Ebola outbreak highlights the ...
A moderately protein-restricted diet is tied to favorable kidney outcomes in patients with chronic kidney disease stage III ...
After a baseball collision, a 51-year-old man presents with bradycardia that progresses to shock; imaging finds a large ...
Changes in gut microbiome diversity are observed with certain antibiotic drugs years later, even after just one course of ...
New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.
Growing evidence suggests that continuous glucose monitoring improves glycemic control, treatment decisions, and patient engagement in people with type 2 diabetes.
The FDA has approved the inhaled human insulin Afrezza (MannKind) for children aged 6 years or older with type 1 diabetes (T1D) or type 2 diabetes (T2D).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results